Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00478335 · ClinicalTrials.gov registry record · NA
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00478335: Completed NA study, sponsored by University of Colorado, Denver.
NCT00478335 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00478335, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if two investigational medications will be more effective in decreasing urine output than the currently available and routinely used medications in patients with congenital nephrogenic diabetes insipidus (NDI).
Primary Outcome
urine volume in mL/d
Interventions
- DRUG sildenafil
- DRUG indomethacin
- DRUG calcitonin
- DRUG hydrochlorothiazide/amiloride
- DRUG Placebo for sildenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-05 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT00478335 record still lists
NCT00478335 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 5 interventions - of which sildenafil is the first listed.
NCT00478335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00478335 about?
NCT00478335 is a clinical study titled "Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus". The purpose of this research study is to determine if two investigational medications will be more effective in decreasing urine output than the currently available and routinely used medications in patients with congenital nephrogenic diabetes insipidus (NDI).
What is the current status of trial NCT00478335?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2007-05. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00478335?
The interventions under investigation include: sildenafil (DRUG), indomethacin (DRUG), calcitonin (DRUG), hydrochlorothiazide/amiloride (DRUG), Placebo for sildenafil (DRUG).
Who is sponsoring clinical trial NCT00478335?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00478335's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia